Regulatory Approvals and Acquisitions Drive Healthcare Sector

Johnson & Johnson (JNJ) received CE Marking for its ACUVUE OASYS MAX 2-Week reusable contact lenses, designed to improve comfort and clarity for patients facing increased screen time and blue-violet light exposure.

The lens will launch in select European markets later this year, with a broader rollout planned in 2027.

JNJ closed Thursday's trading (September 10, 2026) at $266.35, down 0.27%.

Axogen Inc. (AXGN) has entered into a definitive agreement to acquire BioCircuit Technologies, Inc., an advanced neural interface and bioelectronic devices developer, for $200 million in cash.